Policosanol
Sponsors
Drug Commission of the German Medical Association, Rush University Medical Center, James Backes, PharmD, General Hospital of Chinese Armed Police Forces, Seoul National University Bundang Hospital
Conditions
AtherosclerosisCombined HyperlipidemiaDiabetes Mellitus, Type 2DyslipidemiaElevated Blood LipidsEndothelial DysfunctionExercise TrainingHIV Infections
Phase 2
Phase 3
Phase 4
Policosanol in patients with metabolic syndrome and ischaemic cardiopaty
Active, not recruitingRPCEC00000227
Start: 2017-01-15Target: 100Updated: 2026-08-10
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
RecruitingNCT05365425
Start: 2023-06-01End: 2027-12-31Target: 56Updated: 2026-05-05
Policosanol on cognitive impairment after ischemic stroke
Active, not recruitingRPCEC00000475
Start: 2026-06-01Target: 100Updated: 2026-09-14
Unknown Phase
Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy
CompletedNCT00510809
Start: 2007-07-31End: 2010-05-31Updated: 2015-10-08
Effects of Policosanol and Exercise on Fitness and Lipids in People With Elevated Blood Lipids
Not yet recruitingNCT07710261
Start: 2026-06-22End: 2027-01-29Target: 120Updated: 2026-07-17